최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of radiopharmaceuticals and molecular probes : JRMP = 대한방사성의약품학회지, v.3 no.2, 2017년, pp.91 - 97
Park, Jun Young (Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System) , Son, Jeongmin (Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System) , Yun, Mijin (Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System) , Chun, Joong-Hyun (Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System)
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Kawabata S, Higgins GA, Gordon JW. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Nature 1992;356:265.
Bloom GS. Amyloid- ${\beta}$ and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 2014;71:505-508.
Rowe CC, Villemagne VL. Brain amyloid imaging. J Nucl Med 2013;41:11-18.
Chung JK, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A. Cortical Amyloid ${\beta}$ Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment. J Geriatr Psychiatry Neurol 2016;29:149-159.
Nasrallah IM, Wolk DA. Multimodality imaging of alzheimer disease and other neurodegenerative dementias. J Nucl Med 2014;55:2003-2011.
Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. Lancet Neurol 2015;14:114-124.
Okamura N, Harada R, Furukawa K, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y. Advances in the development of tau PET radiotracers and their clinical applications. Ageing Res Rev 2016;30:107-113.
Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y. Characteristics of Tau and Its Ligands in PET Imaging. Biomolecules 2016;6:7.
Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y. $^{18}F$ -THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. J Nucl Med 2016;57:208-214.
Kuntzsch M, Lamparter D, Bruggener N, Muller M, Kienzle GJ, Reischl G. Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(R) 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals. Pharmaceuticals 2014;7:621-633.
Betthauser TJ, Ellison PA, Murali D, Lao PJ, Barnhart TE, Furumoto S, Okamura N, Johnson SC, Engle JW, Nickles RJ, Christian BT. Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau. Appl Radiat Isot 2017;130:230-237.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.